Becoming a heart transplant patient is no small feat. Not only are waitlist times lengthy with no guaranteed end, but the actual transplant procedure is one of the riskiest surgeries performed today.
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results